Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 631 AL 645

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

Xicoy H, Wieringa B, Martens GJ.

Mol Neurodegener. 2017 Jan 24;12(1):10. doi: 10.1186/s13024-017-0149-0.

Non-invasive brain stimulation in Parkinson's disease: Exploiting crossroads of cognition and mood

Dinkelbach L, Brambilla M, Manenti R, Brem AK.

Neurosci Biobehav Rev. 2017 Apr;75:407-418. doi: 10.1016/j.neubiorev.2017.01.021. Epub 2017 Jan 21.

A fixed-dose, dose-response study of ropinirole prolonged release in early stage Parkinson's disease

Zesiewicz TA, Chriscoe S, Jimenez T, Upward J, VanMeter S.

Neurodegener Dis Manag. 2017 Feb;7(1):49-59. doi: 10.2217/nmt-2016-0039. Epub 2017 Jan 25.

A randomized, fixed-dose, dose-response study of ropinirole prolonged release in advanced Parkinson's disease

Zesiewicz TA, Chriscoe S, Jimenez T, Upward J, Davy M, VanMeter S.

Neurodegener Dis Manag. 2017 Feb;7(1):61-72. doi: 10.2217/nmt-2016-0038. Epub 2017 Jan 25.

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

Noncoupled Fluorescent Assay for Direct Real-Time Monitoring of Nicotinamide N-Methyltransferase Activity

Neelakantan H, Vance V, Wang HL, McHardy SF, Watowich SJ.

Biochemistry. 2017 Feb 14;56(6):824-832. doi: 10.1021/acs.biochem.6b01215. Epub 2017 Jan 30.

Functional Neuroanatomy for Posture and Gait Control

Takakusaki K.

J Mov Disord. 2017 Jan;10(1):1-17. doi: 10.14802/jmd.16062. Epub 2017 Jan 18.

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease

Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD.

Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3.

Spotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapy

Annus Á, Vécsei L.

Drug Des Devel Ther. 2017 Jan 9;11:143-151. doi: 10.2147/DDDT.S104227. eCollection 2017.

What Would Dr. James Parkinson Think Today? I. The Role of Functional Neurosurgery for Parkinson's Disease

Hariz M, Obeso JA.

Mov Disord. 2017 Jan;32(1):2-4. doi: 10.1002/mds.26911.

Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: A meta-analysis

Alomar S, King NK, Tam J, Bari AA, Hamani C, Lozano AM.

Mov Disord. 2017 Jan;32(1):53-63. doi: 10.1002/mds.26924.

Effects of Silymarin on Diabetes Mellitus Complications: A Review

Stolf AM, Cardoso CC, Acco A.

Phytother Res. 2017 Mar;31(3):366-374. doi: 10.1002/ptr.5768. Epub 2017 Jan 25.

Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders

Nguyen KT, Pham MN, Vo TV, Duan W, Tran PH, Tran TT.

Curr Drug Metab. 2017;18(9):786-797. doi: 10.2174/1389200218666170125114751.

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Dezsi L, Vecsei L.

CNS Neurol Disord Drug Targets. 2017;16(4):425-439. doi: 10.2174/1871527316666170124165222.

Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds

Borland H, Vilhardt F.

Int J Mol Sci. 2017 Jan 23;18(1):227. doi: 10.3390/ijms18010227.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias